Aspen Pharmacare Holdings Ltd

Aspen Pharmacare Holdings Ltd Organogram

Aspen Pharmacare Holdings Ltd, operating through its subsidiaries, manufactures, markets, imports and distributes branded and generic pharmaceutical products, consumer healthcare, as well as treatment of acute and chronic conditions, covering both hospital and consumer markets through its key business segments. The South African business is split into two portfolios to achieve a heightened customer focus namely, Aspen’s branded portfolio and Ethicare. Aspen presently has a presence in over 50 countries and supplies medicines and products to more than 150 countries. The group operates 23 manufacturing facilities (7 active manufacturing and 16 finished dose form facilities) on 15 sites across 6 continents. Operations are undertaken through the following segments: • Commercial Pharmaceuticals: - Regional Brands - a widely diverse segment comprising predominantly leading domestic brands in the Sub-Saharan Africa, Australasia and Latin American territories • Sterile Focus Brands - focuses on sterile products comprising Anaesthetics Brands and Thrombosis Brands that are distributed to hospitals for use in acute settings - Anaesthetics - includes a range of general anaesthetics, muscle relaxants as well as a number of local anaesthetics including topical agents - Thrombosis - comprises a range of specialist injectable anticoagulants with a focus on low molecular weight heparins, Xa inhibitors and heparin derivatives • Manufacturing: - Contract and supply of chemical and bio-chemicalactive pharmaceutical ingredients and finished dose form pharmaceuticals for third parties Manufacturing sites as follows: 4 - South Africa (Johannesburg; East London; Cape Town; Gqeberha) 2 - Mexico (leased) 3 - The Netherlands 2 - France 1 - Australia 1 - Kenya 1 - Tanzania 1 - Brazil 1 - Germany 1 - USA 1 - Ghana 1 - India